HSCS — HeartSciences Cashflow Statement
0.000.00%
Last trade - 00:00- $15.26m
- $18.96m
- $0.00m
Annual cashflow statement for HeartSciences, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | 2026 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.83 | -6.35 | -6.61 | -8.77 | -9.14 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.033 | 0.38 | 1.01 | 0.797 | 2.77 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.12 | 0.174 | -0.504 | 0.518 | -1.08 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.64 | -5.77 | -6.07 | -7.41 | -7.43 |
| Capital Expenditures | -0.002 | -0.018 | -0.125 | -0.03 | -0.044 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.002 | -0.018 | -0.125 | -0.03 | -0.044 |
| Financing Cash Flow Items | -0.385 | 0 | 0.334 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.84 | 6.53 | 10.3 | 2.73 | 8.03 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.195 | 0.742 | 4.15 | -4.71 | 0.559 |